Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation With ReLEX Smile Surgery
Relex-Smile
1 other identifier
interventional
60
1 country
1
Brief Summary
LASIK (laser-assisted in situ keratomileusis) is a type of refractive surgery for correction of myopia, hyperopia and astigmatism. Yet approximately 30% of operated patients have symptoms like glare, halos, dry eyes and especially residual hypermetrop refractive errors. Residual hypermetrop refractive errors are difficult to treat surgically, the current treatment is Refractive Lens Implantation - risks are similar to those of cataract surgery (endophthalmitis, loss of accommodation, etc.)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 8, 2020
CompletedFirst Submitted
Initial submission to the registry
March 5, 2021
CompletedFirst Posted
Study publicly available on registry
March 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 8, 2025
CompletedFebruary 20, 2024
February 1, 2024
1 year
March 5, 2021
February 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Increase of visual acuity
Increase of visual acuity by reducing residual hypermetropy refractive errors using ReLex Smile (human fresh lenticule implantation) after LASIK.
12 months
Study Arms (1)
Treatment of residual hypermetropia refraction after LASIK
EXPERIMENTALThe main problem at young patients post - LASIK after one year is residual hypermetropic refractive errors (especially accommodation problem) The method used in Eye Hospital is treatment with implantation of human fresh corneal lenticule (min. -1.50D) taken from myopic patients in post - LASIK patients with residual hypermetropic refractive error (min. +1.0D). The flap of LASIk is lifted,cleaned and then the lenticule gently inserted.The lenticule was positioned according the K2 values when is astigmatism residual refractive error.In cases where is not astigmatism the lenticule was positioned in central position under the flap.
Interventions
With the ReLex Smile the optical zone (lenticule diameter) and cap diameter are 6.5 and 7.5 mm respectively. After dissection of both anterior and posterior planes, the lenticule is extracted through 120 degree superior 3.5 mm incision and marked with a sterile marker (ViscotMedster).
Eligibility Criteria
You may qualify if:
- residual hypermetropic refraction,
- low visual acuity
You may not qualify if:
- active anterior segment pathology,
- glaucoma,
- retinae detachment,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eye Hospital Pristina
Pristina, 10000, Kosovo
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Ophthalmology Department
Study Record Dates
First Submitted
March 5, 2021
First Posted
March 11, 2021
Study Start
January 8, 2019
Primary Completion
January 8, 2020
Study Completion
November 8, 2025
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share